A Tribute to Paul Greengard (1925-2019)

<p>1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it<br>Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari<br>2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity<br>Fabio Benfenati, Martin Bähler and Flavia Valtorta<br>3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases<br>Kyle R. Christensen and Angus C. Nairn<br>4. DARPP-32 40 years later<br>Jean-Antoine Girault and Angus C. Nairn<br>5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction<br>Angela M. Lee and Marina R. Picciotto<br>6. Modulation of dendritic spines by protein phosphatase-1<br>Jimcy Platholi and Hugh C. Hemmings Jr<br>7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises<br>Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez<br>8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction<br>Marine Salery, Arthur Godino and Eric J. Nestler<br>9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes<br>Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli<br>10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1<br>Victor Bustos, Maria Pulina and Jose Ledo<br>11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia<br>Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates<br>12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?<br>James K.T. Wang</p>